Patents by Inventor John B. Findlay

John B. Findlay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5582988
    Abstract: Nucleic acids can be made available for amplification or other treatment after lysis by contacting the lysate with specific weakly basic polymers to form a precipitate with the nucleic acids at acidic pH. After removing non-precipitated materials, the pH is then made basic, thereby releasing the nucleic acids from the polymer. This method for preparing specimen samples is simple and quite rapid, and the released nucleic acids can be further treated in hybridization assays or amplification procedures. The weakly basic polymers are water-soluble and cationic at acidic pH, but neutral in charge at basic pH.
    Type: Grant
    Filed: September 15, 1994
    Date of Patent: December 10, 1996
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: John W. Backus, Tobias E. Ekeze, Jerome C. Swartz, Richard C. Sutton, Ignazio S. Ponticello, JoAnne H. Kerschner, John B. Findlay
  • Patent number: 5514550
    Abstract: A nucleic acid test article can be used to detect a targeted nucleic acid found in a specimen. The test article includes a substrate having two opposing surfaces and a water-insoluble nucleic acid probe attached in a distinct zone of one of the surfaces. The probe is prepared from a water-insoluble particle to which is covalently attached an oligonucleotide which is complementary to the targeted nucleic acid. Substantially none of the probe is embedded within the surface of the substrate. Particularly useful test articles have a multiplicity of water-insoluble probes located in distinct zones on one of the substrate surfaces. These probes are useful for the detection of a multiplicity of targeted nucleic acids, particularly after amplification by polymerase chain reaction.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: May 7, 1996
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: John B. Findlay, Janice M. Mayer, Marlene M. King, Fred T. Oakes, Chu-an Chang, Corey H. Levenson
  • Patent number: 5422271
    Abstract: A device and method are disclosed for amplifying and detecting nucleic acid material. The device and method use a label and signalling material responsive to the label to produce a detectable signal. A surprising result of the method and device is that at least one of the wash steps heretofore required has been eliminated without substantially adversely affecting the results.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: June 6, 1995
    Assignee: Eastman Kodak Company
    Inventors: Paul H.-D. Chen, John B. Findlay, Susan M. Atwood, Lynn Bergmeyer
  • Patent number: 5403707
    Abstract: An aqueous composition containing primers for opposing strands of a target retroviral DNA (such as HIV-I DNA) can be used in polymerase chain reaction to provide simultaneously rapid and efficient amplification and detection of that target DNA and one or more additional target DNA's. The primers for each target DNA differ in length by no more than 5 nucleotides and have a T.sub.m within the range of from about 65.degree. to about 74.degree. C., while all of the T.sub.m 's are within about 5.degree. C. of each other. Such compositions are useful in diagnostic test kits and methods for amplification and detection of multiple nucleic acids, or in "multiplexing", using multiple capture probes, all of which have T.sub.m 's which are greater than 50.degree. C. and within 15.degree. C. of each other.
    Type: Grant
    Filed: May 14, 1993
    Date of Patent: April 4, 1995
    Assignee: Eastman Kodak Company
    Inventors: Susan M. Atwood, Thomas J. Cummins, John B. Findlay
  • Patent number: 5328825
    Abstract: An oligonucleotide is linked to a particle through a protein or carbohydrate to form a water-insoluble nucleic acid probe. The protein or carbohydrate has a pI of about 6 or less, and has been chemically modified with an acylating, alkylating or sulfonylating agent. The particle surface is substantially free of other proteins or carbohydrates. The probe is useful in various diagnostic and purification methods wherein hybridization of the oligonucleotide with a target nucleic acid is possible. In one instance, the probe can be used to capture a DNA strand which has been amplified using polymerase chain reaction techniques.
    Type: Grant
    Filed: March 6, 1992
    Date of Patent: July 12, 1994
    Assignee: Eastman Kodak Company
    Inventors: Harold C. Warren, III, John B. Findlay, Marlene M. King
  • Patent number: 5262297
    Abstract: Specific binding methods are used for diagnostic assays and purification separations whereby the specific binding capture reagent is prepared from copolymers having highly reactive carboxy groups. These groups are extended from the polymer surface with a linking group having from 8 to 50 atoms in the chain and two or more alkylene, arylene, alkylenearylene or arylenealkylene groups. To these reactive groups is attached a biologically active substance such as a protein or oligonucleotide which then participates in the diagnostic assays or purification separation methods.
    Type: Grant
    Filed: April 30, 1992
    Date of Patent: November 16, 1993
    Assignee: Eastman Kodak Company
    Inventors: Richard C. Sutton, Susan J. Danielson, John B. Findlay, Fred. T. Oakes, Marsha D. B. Oenick, Ignazio S. Ponticello, Harold C. Warren, III
  • Patent number: 5229297
    Abstract: A cuvette and a method of use which prevent nucleic acid amplified by PCR technology from being released to the atmosphere, while still proceeding to a detection step to determine whether or not the nucleic acid is present. Detection reagents are either pre-incorporated into compartments in the cuvette or added after amplification. In the latter case, a check valve prevents amplified nucleic acid from being released. Transfer of liquids between compartments is achieved via the use of flexible compartment walls and an external pressure source, or via pistons that are part of the cuvette and operate on the compartments as a piston within a piston chamber.
    Type: Grant
    Filed: October 15, 1992
    Date of Patent: July 20, 1993
    Assignee: Eastman Kodak Company
    Inventors: Paul N. Schnipelsky, Leonard J. Seaberg, Charles C. Hinckley, Jeffrey A. Wellman, William H. Donish, John B. Findlay
  • Patent number: 5196305
    Abstract: Methods for amplifying and detecting a predetermined target nucleic acid in a biological specimen are accomplished even where there is a mismatch in a single position between a primer and the target nucleic acid. The mismatch is located at or near the 3' end of the primer. Such a mismatch is overcome using a primer having a nucleotide with a thymine base at the position of the mismatch. The use of such primers is most likely to prime the target and form primer extension products. This method is particularly useful for detection of a nucleic acid sequence which is not fully known, or where there is considerable heterogeneity in DNA target from patient samples.
    Type: Grant
    Filed: September 12, 1989
    Date of Patent: March 23, 1993
    Assignee: Eastman Kodak Company
    Inventors: John B. Findlay, Lynn Bergmeyer
  • Patent number: 5147777
    Abstract: Biologically active reagents are prepared from particles of copolymers having highly reactive carboxy or equivalent groups. The reagents are prepared by covalently attaching biologically active substances, for example antibodies, to the particles, directly or indirectly through highly reactive carboxy groups on the particle surface. These reagents are used to advantage in analytical elements, methods for the detection of specific binding ligands (such as immunological species) and immunoassays, and in purification methods as affinity chromatography reagents.
    Type: Grant
    Filed: June 18, 1990
    Date of Patent: September 15, 1992
    Assignee: Eastman Kodak Company
    Inventors: Richard C. Sutton, Susan J. Danielson, John B. Findlay, Fred T. Oakes, Marsha D. B. Oenick, Ignazio S. Ponticello, Harold C. Warren, III
  • Patent number: 4788140
    Abstract: A multilayer analytical element for the determination of a clinically significant enzyme analyte comprises a photosensitive compound (e.g. a photosensitive dye or dye precursor) and a filter layer containing one or more filter dyes. The filter layer is situated in the element such that incident radiation used to detect a density change resulting from interaction of the analyte and the photosensitive compound passes through the filter layer before it reaches the photosensitive compound. The use of the filter layer inhibits premature changes in the photosensitive compound caused by incident radiation. This element is particularly useful for the determination of creatine kinase or one of its isoenzymes, e.g. creatine kinase-MB.
    Type: Grant
    Filed: February 18, 1986
    Date of Patent: November 29, 1988
    Assignee: Eastman Kodak Company
    Inventors: John B. Findlay, Brent A. Burdick, Ronald A. Wellman, Mark E. Shafer
  • Patent number: 4713327
    Abstract: A multilayer analytical element for the determination of creatine kinase comprises a support having thereon, in order and in fluid contact, a registration layer and an isotropically porous spreading layer. The registration layer contains a binder material at a coverage of at least about 8 g/m.sup.2, which coverage improves the stability and keeping properties of the element in high humidity environments. This element is useful in an analytical method for determining total creatine kinase or any one of its isoenzymes, e.g. creatine kinase-MB.
    Type: Grant
    Filed: May 1, 1985
    Date of Patent: December 15, 1987
    Assignee: Eastman Kodak Company
    Inventors: John B. Findlay, Annie L. Wu, Gary E. Norton
  • Patent number: 4703002
    Abstract: A method for preparing a blush polymer coating composition containing an immunologically reative species comprises milling the species and the other materials used in the composition to uniformly disperse the species therein. This coating composition can be used to prepare analytical elements for determining analytes (e.g. creating kinase-MB) whereby the effects of potential interferents are immunochemically removed. By milling the immunologically reactive species, e.g. antisera, into the coating composition, the resulting element has improved stability resulting in improved keeping in high humidity environments.
    Type: Grant
    Filed: May 1, 1985
    Date of Patent: October 27, 1987
    Assignee: Eastman Kodak Company
    Inventors: John B. Findlay, Annie L. Wu
  • Patent number: 4547461
    Abstract: An enzymatic method for the analytical determination of creatine kinase in an aqueous liquid such as blood serum is described. The determination is made by measuring an optical density change using the reagents creatine phosphate, adenosine diphosphate, glycerol, glycerol kinase, .alpha.-glycerophosphate oxidase, a chromagen and a mercapto-containing creatine kinase activator. The mercapto-containing creatine kinase activator is added in encapsulated form or in low concentrations so as to preserve the activity of the chromagen.
    Type: Grant
    Filed: January 18, 1983
    Date of Patent: October 15, 1985
    Assignee: Eastman Kodak Company
    Inventors: Theodore W. Esders, Shirley Y. Lynn, John B. Findlay, Richard M. Schubert